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Background: Practice guidelines recommend waiting 5 to 7 days after thienopyridine discontinuation before cardiac surgery. The objective of this 
study was to investigate the relationship between the time from drug discontinuation and the recovery of platelet function. 
Methods: Fifty-six aspirin-treated subjects with stable coronary artery disease were randomized to either prasugrel 10 mg or clopidogrel 75 mg 
daily for 7 days after which study drug was discontinued. Platelet reactivity was assessed by the VerifyNow P2Y12 test prior to study drug treatment 
(baseline) and for up to 12 days during washout. The primary outcome was the cumulative proportion of subjects who returned to baseline reactivity 
following study drug discontinuation.
Results: The figure shows the proportion of subjects returning to baseline reactivity according to treatment arm. The proportion of subjects in the 
prasugrel group that had returned to baseline by washout Day 7 was similar to that of the clopidogrel group by Day 5 (78% and 85%, respectively). 
By regression analysis, the time to recovery was dependent upon the level of baseline reactivity and the level of inhibition on the first day of 
discontinuation, independent of study drug assignment. 
Conclusions: Although the relationship between ex vivo platelet reactivity and surgical bleeding is unclear, the findings of this study are 
consistent with current guidelines regarding the recommended waiting time for surgery after discontinuation of prasugrel or clopidogrel therapy. 
